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Abstract. 
 
Caveolin-1 is normally localized in plasma
membrane caveolae and the Golgi apparatus in mam-
malian cells. We found three treatments that redirected
the protein to lipid storage droplets, identiﬁed by stain-
ing with the lipophilic dye Nile red and the marker pro-
tein ADRP. Caveolin-1 was targeted to the droplets
when linked to the ER-retrieval sequence, KKSL, gen-
 
erating Cav–KKSL. Cav–
 
D
 
N2, an internal deletion mu-
tant, also accumulated in the droplets, as well as in a
Golgi-like structure. Third, incubation of cells with
brefeldin A caused caveolin-1 to accumulate in the
droplets. This localization persisted after drug washout,
showing that caveolin-1 was transported out of the
droplets slowly or not at all. Some overexpressed cave-
olin-2 was also present in lipid droplets. Experimental
reduction of cellular cholesteryl ester by 80% did not
prevent targeting of Cav–KKSL to the droplets. Cav–
KKSL expression did not grossly alter cellular triacylg-
lyceride or cholesteryl levels, although droplet mor-
phology was affected in some cells. These data suggest
that accumulation of caveolin-1 to unusually high levels
in the ER causes targeting to lipid droplets, and that
mechanisms must exist to ensure the rapid exit of newly
synthesized caveolin-1 from the ER to avoid this fate.
Key words: caveolae • brefeldin A • retrograde trans-
port • triacylglycerol • cholesteryl ester
 
Introduction
 
Caveolae, 50–100-nm plasma membrane pits, have been
implicated in functions as diverse as signal transduction,
cholesterol transport, and endocytosis (Kurzchalia and
Parton, 1999; Smart et al., 1999). A useful approach to
understanding caveolae is to study caveolin-1, an impor-
tant structural protein of caveolae that is required for
their formation (Fra et al., 1995). The mammalian cave-
olin gene family also includes the widely expressed ca-
veolin-2 and the muscle-specific caveolin-3 (Smart et
al., 1999).
Caveolin-1 has been proposed to move from the ER
through the cytosol directly to the plasma membrane, in
a complex with molecular chaperones, as part of an un-
usual intracellular cycling itinerary (Uittenbogaard et al.,
1998). The present study was initiated to test this idea.
Resident ER membrane proteins that escape from the
ER are efficiently retrieved through recognition of a
KKXX signal on their COOH termini by the COPI com-
plex (Letourneur et al., 1994). We appended the se-
quence KKSL to the COOH terminus of Myc-tagged ca-
nine caveolin-1, generating Cav–KKSL. We reasoned
that if caveolin-1 must traverse the ER–Golgi intermedi-
ate complex and Golgi apparatus after leaving the ER,
then Cav–KKSL, like other KKXX-tagged proteins,
would not reach the plasma membrane. Alternatively, if
some caveolin-1 moved directly from the ER to the
plasma membrane, it would bypass the retrieval compart-
ments and accumulate in the plasma membrane.
As described here, we found essentially no Cav–KKSL
in the plasma membrane, suggesting that the protein al-
ways entered the retrieval compartments. However, in-
stead of being restricted to the ER, Cav–KKSL displayed
a novel localization to large round structures that we
found were lipid storage droplets.
Eukaryotic cells store neutral lipids in cytoplasmic
droplets (Londos et al., 1999; Murphy and Vance, 1999).
Although formation of these droplets is especially well
developed in adipocytes and in certain plant cells, they
are present in a variety of mammalian cell types. Lipid
droplets bud from the ER, and are thought to be sur-
rounded by a phospholipid monolayer enriched in cer-
tain proteins. Adipocyte differentiation related protein
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(ADRP),
 
1
 
 which has a wide tissue distribution in animal
cells, is among the best characterized of these. ADRP as-
sociates specifically with lipid storage droplets, and not
with the ER from which the droplets are derived, and is
thus a useful marker of the droplets (Londos et al., 1999).
Localization of Cav–KKSL to these droplets was sur-
prising, as endogenous caveolin-1 is never seen there.
Characterizing this localization became the focus of this
project.
 
Materials and Methods
 
Materials
 
Fischer rat thyroid (FRT) cells (Lipardi et al., 1998), the gift of Dr. En-
rique Rodriguez-Boulan (Cornell University, Ithaca, New York), were
maintained in Coon’s F12 media with 10% FBS. COS, CHO, and HEK
293 cells (American Type Culture Collection) were maintained in DME
with 5% iron-supplemented calf serum or 10% FBS.
All caveolin-1 constructs were derived from canine caveolin-1 (VIP21;
Kurzchalia et al., 1992). HA/myc-tagged caveolin-1 has been described
(Dietzen et al., 1995). Cav–
 
D
 
N2, lacking residues T46–T95, was generated
from HA/myc-tagged caveolin-1 by PCR. Plasmid SAV2MK1 (derived
from SMH3, a COS cell expression vector with an adenovirus major late
promoter) encodes caveolin-1 with the COOH-terminal extension GVD-
MEQKLISEEDLNSKKSL, including a myc tag and then KKSL. The
control plasmid, SAV2M2, lacked the COOH-terminal KKSL. A GFP-
tagged caveolin-1 cDNA was constructed by subcloning the HA/myc-
tagged caveolin-1 as a 0.6-kb XhoI/ApaI fragment (Dietzen et al., 1995)
into the same sites in pEGFP-C1 (CLONTECH), yielding an in-frame fu-
sion with GFP at the NH
 
2
 
 terminus of caveolin-1. Human caveolin-2 from
an EST clone (GenBank/EMBL/DDBJ accession no. AA150110) from
Research Genetics was cloned by PCR into pCGN (Tanaka and Herr,
1990) to fuse an HA epitope tag to the NH
 
2
 
 terminus of the protein.
Transient transfections used Lipofectamine 2000, Lipofectamine Plus
(Life Technologies), or Fugene 6 (Roche), examining cells 24–48 h after
transfection. FRT cells were stably transfected using calcium phosphate,
selecting with G418.
 
Antibodies
 
Antibodies used: rabbit anti–caveolin-1 antibodies (#13630, BD Transduc-
tion Laboratories). Mouse anti-HA IgG (clone 12CA5) was the gift of Dr.
Neta Dean (SUNY Stony Brook, Stony Brook, NY). Mouse anti-myc IgG
(Invitrogen). Mouse anti-ADRP (ProGen). Dichlorotriazinylaminofluo-
rescein (DTAF)- and Texas red-conjugated goat–anti rabbit and anti–
mouse IgG (Jackson ImmunoResearch).
Pfizer’s acyl CoA:cholesterol acyl transferase (ACAT) inhibitor CP
113,818 (Warner et al., 1995) was the gift of Dr. George Rothblat (Chil-
dren’s Hospital of Philadelphia, Philadelphia, PA). Brefeldin A (BFA),
Nile red, and FITC-conjugated lens lectin were from Sigma Chemical Co.
 
Fluorescence Microscopy
 
Immunofluorescence (IF) microscopy was as described (Arni et al., 1998),
except that cells used for Nile red staining were permeabilized for 5 s on
ice in PBS/0.05% Triton X-100. Fluorescent images of cells were captured
into Adobe Photoshop from a SPOT cooled CCD 24 bit color digital cam-
era (Diagnostic Instruments) mounted on a Zeiss Axioskop 2 microscope.
For double labeling, images in two channels were collected separately and
then overlaid in Photoshop. Where appropriate, coverslips were incu-
bated with 100 nM Nile red in PBS for 10 min. Nile red was detectable in
both DTAF and Texas red channels. Double labeling with DTAF was
possible because the Nile red staining bleached rapidly. After collection of
Nile red images, the Nile red fluorescence was completely bleached to re-
veal the DTAF fluorescence.
 
Reduction of Cholesteryl Ester (CE) Levels
 
Day 0, FRT cells were transferred to Coon’s F12 media containing 10% li-
poprotein-depleted serum (LPDS; Goldstein et al., 1983) or cells were left
in control media. Day 5, cells were transfected with Cav–KKSL. The
ACAT inhibitor CP 113,818 (2 
 
m
 
g/ml) was added to the dish containing
LPDS 24–36 h before harvest. Cells were fixed for detection of Cav–
KKSL
 
 
 
by IF or were subjected to lipid extraction to quantitate CE.
 
Quantitation of CE and Triacylglyceride (TG)
 
In Fig. 6 A, lipids in confluent cell monolayers in 35-mm dishes were ex-
tracted as reported previously (Brown and Rose, 1992). In Fig. 7 A, cells
were seeded in parallel 60-mm dishes (for lipid extraction) and 35-mm
dishes with coverslips (for IF, staining for Cav–KKSL and counterstaining
with DAPI to determine the percent of cells that were transfected). For
transient transfections, the same transfection mixture was used for both
dishes. Nonpolar lipids from cells in confluent 60-mm dishes were ex-
tracted with hexane/isopropyl alcohol 3:2 (Underwood et al., 1998). In
Figs. 6 A and 7 A, extracted lipids (100% of the FRT and HEK 293 ex-
tracts or 10% of the COS extracts) were separated by high-performance
thin-layer chromatography (HP-TLC) using hexane/isopropyl ether/acetic
acid 65:35:2, and visualized by charring and quantitated by densitometric
scanning and comparison to standards on the same plate as described
(Brown and Rose, 1992). Cholesterol, not expected to accumulate in lipid
droplets, was also scanned as an internal control.
 
Results
 
Cav–KKSL Exhibits a Novel Localization
 
Cav–KKSL was expressed transiently in FRT cells, which
lack endogenous caveolin-1 and caveolae (Lipardi et al.,
1998), or in COS cells, which express caveolin-1 endoge-
nously (Fig. 1). Cav–KKSL was not detected in the plasma
membrane, suggesting that direct transport from the ER
to the plasma membrane (Uittenbogaard et al., 1998) is at
most a minor pathway. In some cells, Cav–KKSL was de-
tectable in the ER (Fig. 1 C). In most cells, however, the
protein accumulated predominantly on the surface of
spherical structures that varied in size and were often, but
 
1
 
Abbreviations used in this paper:
 
 ACAT, acyl CoA:cholesterol acyl trans-
ferase; ADRP, adipocyte differentiation related protein; BFA, brefeldin
A; CE, cholesteryl ester; DTAF, dichlorotriazinylaminofluorescein; FRT,
Fischer rat thyroid; IF, immunofluorescence; LPDS, lipoprotein-depleted
serum; TG, triacylglyceride.
Figure 1. Localization of Cav–KKSL. Cav–KKSL in transiently
transfected FRT (A and B) or COS (C and D) cells was visual-
ized by IF. 
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not always, clustered together. Cav–KKSL was also seen
in these structures when expressed in HEK-293 and CHO
cells, although ER staining was more prominent than in
the other two lines (not shown).
 
Cav–KKSL-positive Structures Are Lipid
Storage Droplets
 
To determine whether the Cav–KKSL-positive structures
were lipid storage droplets, Cav–KKSL-expressing FRT
cells were double-labeled with antibodies to Cav–KKSL
and with either Nile red or with antibodies to ADRP. Nile
red stained the lipid droplet cores, whereas both Cav–
KKSL and ADRP were localized to the surface of the
droplets (Fig. 2). In some transfected cells, almost all Nile-
red positive droplets were also positive for Cav–KKSL. In
others (Fig. 2 F), some droplets stained only for Nile red.
 
An Internal Deletion Mutant of Caveolin-1 
Accumulates in Lipid Droplets
 
We also examined the localization of Cav–
 
D
 
N2, a mutant
made for unrelated studies, that lacks residues 46–95 of ca-
veolin-1, including almost the entire downstream half of
the NH
 
2
 
-terminal hydrophilic domain. In some cells, Cav–
 
D
 
N2 was present in the Golgi apparatus (identified as a
 
perinuclear structure labeled with FITC-lens lectin, not
shown). However, in most cells the protein was present in
lipid droplets, identified by their characteristic morphol-
ogy. Both patterns are evident in the cell shown in Fig. 3
A. The presence of Cav–
 
D
 
N2 in lipid droplets showed that
the KKSL tag is not required for the accumulation of Cav–
KKSL in the droplets. We also conclude that residues 46–
95, which include most of the caveolin scaffolding domain
previously reported to mediate binding of caveolin-1 to
other proteins (Smart et al., 1999), are not required for
lipid droplet targeting.
 
Accumulation of Caveolin-1 in the ER with Brefeldin A 
Targets the Protein to Lipid Droplets
 
What might Cav–KKSL and Cav–
 
D
 
N2 have in common
that is not shared by caveolin-1, that could explain the ac-
cumulation of both proteins in lipid droplets? One possi-
bility is accumulation to unusually high levels in the ER.
Retrieval of Cav–KKSL to the ER should increase its
concentration there. Cav–
 
D
 
N2 might fold slowly, or
might lack a domain required for interaction with a cargo
receptor and efficient packaging into transport vesicles.
Either effect would retard transport of the protein from
the ER. In contrast, caveolin-1 is probably normally
Figure 2. Colocalization of Cav–KKSL, ADRP, and Nile red staining. Endogenous ADRP (A) and transiently expressed Cav–KKSL
(B) in a COS cell were visualized by IF. C, Merged image of A and B. Nile red stain (D) and IF visualization of Cav–KKSL (E) in a
transiently transfected FRT cell. F, Merged image of D and E. 
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transported efficiently from the ER, never reaching a
high concentration there.
To determine whether ER accumulation is sufficient to
target caveolin-1 to lipid droplets, we incubated FRT cells
transiently transfected with caveolin-1 for 5 h in BFA to
collapse the Golgi apparatus into the ER (Lippincott-
Schwartz et al., 1989). Both Golgi apparatus-localized and
newly synthesized caveolin-1 should accumulate in the ER
during BFA treatment. IF localization of caveolin-1 in
control, untreated cells showed the expected punctate
plasma membrane staining and Golgi apparatus staining
(Fig. 4 A). (Golgi apparatus staining of caveolin-1 in trans-
fected FRT cells was often more pronounced than in cells
that express caveolin-1 endogenously.) The Golgi appara-
tus, detected with lens lectin, had the expected morphol-
ogy in control cells (Fig. 4 D). As expected, lens lectin
staining assumed a diffuse ER-like pattern after BFA treat-
ment (Fig. 4 E). Caveolin-1 was detectable in lipid droplets
in about half of the transfected cells after BFA treatment
(Fig. 4 B), and showed a punctate or reticular pattern in
the other cells (not shown). BFA also induced accumula-
tion of GFP-tagged caveolin-1 in lipid droplets in living
CHO cells (not shown).
What is the fate of caveolin-1 in lipid droplets? One pos-
sibility is that caveolin-1 normally passes through lipid
droplets while cycling through the cell. Alternatively, ca-
veolin-1 may not normally enter the droplets. If endoge-
nous caveolin-1 normally travels through the droplets, it
must exit from them rapidly, as the protein is not detected
there at steady-state. To determine how rapidly caveolin-1
moves out of the droplets, we took advantage of the fact
that the known effects of BFA are readily reversible upon
drug washout. We incubated FRT cells for 5 h with BFA,
washed out the drug, and incubated for 3 h before fixing
and staining for caveolin-1. The Golgi apparatus reas-
sumed its normal morphology in this time (Fig. 4 F). How-
ever, caveolin-1 was still observed in lipid droplets in
about half the transfected cells (Fig. 4 C). Thus, transport
of caveolin-1 out of lipid droplets after BFA washout was
slow or did not occur, suggesting that the droplets are not
on the normal transport pathway.
 
Overexpressed Caveolin-2 Accumulates in Lipid 
Droplets and in the Golgi Apparatus 
 
Endogenous or stably overexpressed caveolin-2 accumu-
lates in the Golgi apparatus in FRT cells (Mora et al.,
1999). We found that HA-tagged caveolin-2 also accumu-
lated in the Golgi apparatus in transiently transfected FRT
cells (Fig. 3 B). Surprisingly, caveolin-2 was also detected
in lipid droplets in 30–50% of the transiently transfected
cells (Fig. 3 B). GFP-tagged caveolin-2 was also seen in
lipid droplets in living CHO cells (not shown). By contrast,
GFP–caveolin-1 was not seen in lipid droplets in CHO
Figure 3. Localization of Cav–DN2 and caveolin-2. IF localiza-
tion of Cav–DN2 (A) and caveolin-2 (B) in transiently trans-
fected FRT cells. The Golgi apparatus was overexposed to show
the droplets.
Figure 4. Effect of BFA on caveolin-1
localization. FRT cells were transiently
transfected with HA/myc-tagged cave-
olin-1. Cells were either left untreated
(A and D) or BFA-treated for 5 h (B,
C, E, and F). BFA-treated cells were
either fixed immediately (B and E) or
were incubated at 378C for 3 h in nor-
mal growth media after washing out
BFA before fixation (C and F). Caveo-
lin-1 was visualized by IF (A–C). Golgi
apparatus morphology in cells on sepa-
rate coverslips was monitored using
FITC-lens lectin (D–F). Experiments
in which caveolin-1 and lens lectin
staining were visualized in the same
cells gave similar results (not shown). 
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cells, and overexpressed caveolin-1 was only very occa-
sionally (
 
,
 
0.1% of transfected cells) seen in lipid droplets
in FRT cells without BFA treatment (not shown). We con-
clude that caveolin-2, as well as caveolin-1, can enter the
droplets. Caveolin-2, unlike caveolin-1, can readily be tar-
geted to the droplets by overexpression. Inefficient trans-
port of caveolin-2 through the secretory pathway (Mora et
al., 1999) may cause this targeting. The similar localization
of overexpressed Cav–
 
D
 
N2 and caveolin-2 (Fig. 3, A and
B) suggests that folding or transport rates of the two pro-
teins may be similarly slow.
 
Caveolin-1 Accumulates in Lipid Droplets When 
Coexpressed with Cav–KKSL
 
If the presence of high levels of caveolin in the ER is suffi-
cient to cause lipid droplet targeting, then coexpression with
Cav–KKSL, which accumulates in the ER, should divert
some caveolin-1 to the droplets. To test this idea, myc-
tagged Cav–KKSL and HA/myc-tagged caveolin-1 were
transiently coexpressed in FRT cells. As expected, anticave-
olin antibodies, which recognized both proteins, stained
both lipid droplets and the plasma membrane (Fig. 5 A).
Anti-HA antibodies, which recognized only caveolin-1, gave
a similar staining pattern (Fig. 5 B). Thus, coexpression with
Cav–KKSL redirected some caveolin-1 to lipid droplets.
This targeting might result from accumulation of caveolin in
the ER, as we have suggested. Alternatively, it might result
from heterooligomerization of caveolin-1 and Cav–KKSL.
 
Cholesterol Ester Depletion Does Not Affect the 
Localization of Cav–KKSL
 
ACAT, which converts free cholesterol to CE that accu-
mulates along with TG in lipid storage droplets, is local-
ized in the ER. As caveolin-1 binds cholesterol and can as-
sociate with cholesterol-rich lipid microdomains (Smart et
al., 1999), we wondered whether CE were required for tar-
geting of Cav–KKSL to lipid droplets, possibly through
tight binding of Cav–KKSL to CE. To test this model,
we determined whether inhibiting ACAT affected Cav–
KKSL localization. Cellular CE levels were reduced by
70–80% by growth in LPDS and CP 113,818 treatment
Figure 5. Partial recruitment of caveo-
lin-1 to lipid droplets by Cav–KKSL.
FRT cells were transiently cotrans-
fected with Cav–KKSL and HA/Myc-
tagged caveolin-1 and double-labeled
with anti-caveolin-1 antibodies and
Texas-red secondary antibodies (A; to
detect both proteins) and anti-HA an-
tibodies and DTAF secondary anti-
bodies (B; to detect the wild-type
protein specifically). Arrow, plasma
membrane staining; arrowheads, lipid
droplets.
Figure 6. CE depletion does not affect Cav–KKSL localiza-
tion. A, FRT cells in 100-mm dishes were grown as usual
(Control) or depleted of CE as described in Materials and
Methods (Depleted). The indicated fraction of the total lipids
isolated from each plate was then analyzed by HP-TLC as in
Materials and Methods. The charred CE bands are shown. The
levels of other lipids were not affected (not shown). B–E,
Cav–KKSL in CE-depleted FRT cells transiently expressing
Cav–KKSL was visualized by IF. The range of staining pat-
terns was identical to that in control cells processed in parallel
(not shown). 
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(Fig. 6 A). Cells were then transfected with Cav–KKSL
and examined by IF (Fig. 6, B–E). Cav–KKSL localization
appeared unaffected by CE reduction. We conclude that
high levels of newly synthesized CE are not required for
targeting of Cav–KKSL to lipid droplets.
 
Effect of Cav–KKSL Expression on Lipid Droplets
 
We first determined whether Cav–KKSL affected cellular
levels of TG and CE, the major storage lipids in mamma-
lian cells. The behavior of perilipins, proteins that coat
lipid droplets in adipocytes, provides a precedent for this
idea. Overexpression of perilipins inhibits TG hydrolysis,
causing TG to accumulate (Brasaemle et al., 2000).
To this end, we first selected stable Cav–KKSL transfec-
tants from FRT cells. Generating these lines was difficult,
and only two were obtained. Furthermore, Cav–KKSL
was detectable by IF in only 10–20% of the cells in each
line, although caveolin-1 was detectable in essentially all
cells in a stably transfected FRT cell line (Lipardi et al.,
1998) (not shown). These results raised the possibility that
Cav–KKSL was harmful to cells, and that the two stable
transfectants were abnormal. For this reason, we also ex-
amined the effect of transient Cav–KKSL expression on
TG and CE levels in FRT, COS, and HEK 293 cells. Cav–
KKSL expression had no significant effect on TG or CE
levels in any of these cells (Fig. 7 A). As the transient
transfection efficiency was 
 
z
 
30–50% (see legend to Fig. 7
A), a large effect should have been detectable.
To determine whether Cav–KKSL affected lipid droplet
morphology, we compared Cav–KKSL-positive droplets
in transiently transfected COS and FRT cells with Nile
red-positive droplets in untransfected cells. Lipid droplets
were present in untransfected cells (Fig. 7, B and C).
Droplet size and number varied widely among cells, espe-
cially in FRT cells (Fig. 7 B). However, in these cells the
range appeared similar to that in Cav–KKSL-positive cells
after transient transfection (Figs. 1, 2, and 6). Although
this suggested that Cav–KKSL did not affect lipid droplet
structure, the heterogeneity made this difficult to deter-
mine precisely. However, lipid droplets were clustered in
many (but not all) Cav–KKSL-positive cells (Figs. 1 and
6), but not in untransfected cells (Fig. 7). Interaction be-
tween Cav–KKSL molecules on adjacent droplets may
cause them to cluster.
In COS cells, Cav–KKSL-positive lipid droplets looked
similar to Nile red positive droplets in many cells. How-
ever, the largest droplets appeared larger than the largest
droplets seen in control cells (Fig. 7 C; also see Fig. 1 D),
suggesting that Cav–KKSL can increase lipid droplet size.
 
Discussion
 
How Caveolins Might Access Lipid Droplets
 
Lipid droplet biogenesis is not well understood (Londos et
al., 1999; Murphy and Vance, 1999). However, the prevail-
ing model rationalizes how caveolins (but not most other
membrane proteins) might be able to enter the droplets
(Fig. 8). Lipid droplets are derived from the ER, where
TG and CE are synthesized, and are thought to be sur-
rounded by a phospholipid monolayer (Londos et al.,
1999; Murphy and Vance, 1999). These observations sug-
gest that neutral lipids accumulate in the hydrophobic core
of the bilayer, forming a bulge that eventually buds from
the ER membrane to form a free droplet. Accumulation of
neutral lipids in the bilayer core would initially force op-
posite leaflets of the bilayer apart, increasing bilayer thick-
ness. Such a thickened bilayer would not be able to accom-
modate transmembrane proteins that have hydrophilic
domains on both sides of the membrane, and these pro-
teins would be excluded from the forming droplets. Cave-
olins, by contrast, lack luminal hydrophilic domains, and
could diffuse freely between the ER membrane and the
monolayer surrounding the nascent droplet. Thus, caveo-
lins would not need to dissociate from the ER membrane
Figure 7. Effect of Cav–KKSL on lipid droplets. A, Lipids from
various cell types were separated by HP-TLC and visualized by
charring. Lanes 1 and 2 are from a separate plate. Positions of
CE, TG, and unidentified lipid X are indicated. Cells used and
(percent of cells expressing Cav–KKSL); 1, G418-resistant FRT
cells; 2, FRT clone B4 stably expressing Cav–KKSL (19%); 3,
transient FRT/vector; 4, transient FRT/Cav–KKSL (32%); 5,
COS/vector; 6, COS/Cav–KKSL (36%); 7, HEK 293/vector; 8,
HEK 293/Cav–KKSL (53%). Only 10% of the COS cell extracts
(lanes 5 and 6) were loaded on the plate. B, Untransfected FRT
cells were stained with Nile red. C, COS cells were transiently
transfected with Cav–KKSL, detecting the protein by IF (left), or
were stained with Nile red (right; a cell with large droplets). 
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and expose their hydrophobic domains to the cytosol to
enter the droplets. This model suggests that caveolins can
enter lipid droplets only while they are forming, and are
still in contact with the ER. Consistent with this idea, we
noticed that in some transfected cells, only some of the
Nile red positive droplets contained Cav–KKSL (Fig. 2).
We speculate that the Cav–KKSL-negative droplets bud-
ded from the ER before expression of Cav–KKSL started.
 
Why Might Caveolins Sometimes Accumulate in
Lipid Droplets?
 
Our results suggest that accumulation of caveolins in the
ER leads to lipid droplet targeting, and we favor this
model. However, an alternate possibility is that transport
of caveolins to the ER via a retrograde pathway somehow
leads to lipid droplet targeting. Retrograde transport is ex-
pected for Cav–KKSL, as KKXX-tagged proteins are
known to follow this route (Letourneur et al., 1994). Cave-
olins in BFA-treated cells may also undergo retrograde
transport. Because BFA does not inhibit COPII-coated
vesicle formation (Bednarek et al., 1995), COPII-coated
vesicles may continue to bud from the ER and possi-
bly even reach the ER to Golgi intermediate complex
(ERGIC; which does not collapse into the ER; Schweizer
et al., 1993) during BFA treatment. If so, the cargo pro-
teins must be rapidly recycled to the ER. Finally, mis-
folded proteins bound to chaperones can also be retrieved
from the ERGIC and Golgi apparatus to the ER (Ham-
mond and Helenius, 1994). Inefficient transport of caveo-
lin-2 in the absence of caveolin-1 and of Cav–
 
D
 
N2 suggests
that these proteins may not fold properly.
Although we do not know how ER accumulation of ca-
veolins might lead to an apparent concentration of the pro-
teins in lipid droplets, several possible explanations can be
imagined. First, caveolins might have a high affinity for
lipid droplets, either through binding to a protein or lipid in
the droplets, or through preference for the physical state of
the droplet phospholipid monolayer or neutral lipid core.
Efficient packaging of caveolins into transport vesicles
might normally prevent entry into the droplets. Accumula-
tion in the ER might saturate some component of the
transport machinery, possibly a specific cargo receptor, giv-
ing the protein time to access the droplets. Alternatively,
accumulation of caveolins in the ER might change the
properties of the ER membrane. As caveolin-1 binds cho-
lesterol (Smart et al., 1999), this might occur through accu-
mulation of cholesterol in the ER. The altered properties
might increase the affinity of caveolins for lipid droplets, ei-
ther by changing the physical properties of the membrane,
or by inducing a conformational change in caveolins.
Intriguingly, oleosins, a family of plant lipid-droplet pro-
teins (Murphy and Vance, 1999), have a similar topology
to caveolins, with a central hydrophobic domain flanked
by two cytoplasmic domains. Lipid droplet targeting sig-
nals are contained in the hydrophobic domain (Abell et
al., 1997). Further work will show whether the unusual
topology, the hydrophobic domain, or any specific se-
quences are required for lipid droplet targeting and/or ac-
cumulation of caveolins.
 
Physiological Relevance of Lipid Droplet Targeting
of Caveolins
 
We do not know whether caveolins normally pass through
lipid droplets during biosynthetic transport or intracellular
cycling. If they do, they must exit the droplets rapidly, as
they are not normally detected there. Thus, our finding
that caveolin-1 remained in lipid droplets long after BFA
washout, suggesting that transport of caveolins from the
droplets is slow, implies that caveolins do not normally
pass through the droplets. However, it remains possible
that caveolins may be transported to the droplets under
as-yet-unidentified conditions.
We do not know how (or whether) caveolins function in
the droplets. Cav–KKSL appeared to increase the size and
possibly the abundance of lipid droplets in some COS
cells, which contain much more TG than the other cells we
examined. We did not detect an effect of Cav–KKSL on
CE or TG levels in a population of transiently transfected
cells. However, our assay might not have detected an in-
crease if Cav–KKSL induced lipid accumulation in a sub-
set of transfected cells. Such an effect could occur if Cav–
KKSL sterically blocked access of lipases to the droplets,
as is thought to occur in cells overexpressing perilipins
(Brasaemle et al., 2000). Accumulation of caveolins in
lipid droplets might also affect cholesterol trafficking, as
shown for a dominant-negative caveolin mutant in the ac-
companying paper (Pol et al., 2001, this issue).
In any case, the unusual targeting we have identified
here may provide clues to the puzzle of how caveolins nor-
mally interact with lipids in caveolae and other mem-
branes.
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